A research team has introduced a novel cancer immunotherapy strategy. This approach involves attaching "fake targets" to tumor cells to guide immune cell attacks, overcoming the limitations of conventional antibody-based therapies. The study is published in ACS Nano.
Read Original
The Media Hub: The Kings Ark™
